The University of Texas Medical Branch · 2 months ago
Research Associate I (Microbiology and Immunology - Galveston)
0610 - GNL Bldg301 University Blvd.
Full-time
Onsite
New Grad, Entry Level
0+ years expThe University of Texas Medical Branch is seeking a Research Associate I to perform standardized laboratory assignments and experiments. The role involves conducting research experiments, preparing biological assays, maintaining records, and assisting in data analysis under supervision.
Hospital & Health Care
No H1B
U.S. Citizen Only
Responsibilities
Under direct supervision, performs standard research assignments involving a series of related operations
Sets up and conducts standard research experiments following detailed technical instructions
Prepares biological assays and conducts basic quantitative and qualitative analysis
Maintains records of all tests performed and data collected
Assists in the compilation and tabulation of data and provides preliminary analysis
Assembles, calibrates, operates and makes minor modifications to a variety of laboratory equipment as defined by appropriate guidelines
Adheres to internal controls established for department
Performs related duties as required
Qualification
Required
Bachelor's degree in basic science or equivalent and no experience required
Preferred
More than two years of experience maintaining mammalian cell cultures is highly preferred
More than two years of experience performing plaque assays, virus neutralization assays, and ELISAs is highly preferred
More than two years of experience working with viruses in BSL-3 or BSL-4 is preferred
The ideal candidate would have a DOJ clearance and more than two years of BSL-3 or BSL-4 experience working with cell cultures, viruses, and laboratory animals
Proficient in molecular biology techniques (PCR, cloning, serological assays, flow cytometry)
Company
The University of Texas Medical Branch
The University of Texas Medical Branch is a component of the University of Texas System located in Galveston, Texas
10001+ employees
Funding
Current Stage
Late StageTotal Funding
$35MKey Investors
National Institute of Allergy and Infectious Diseases
2024-09-13Grant
2019-04-09Grant· $35M
Leadership Team
Donna Sollenberger
EVP and CEO, Health System
Recent News
2025-10-30
Quetzal Therapeutics
2025-09-17
EIN Presswire
2025-08-25
Company data provided by crunchbase